![Dov Elefant](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dov Elefant
Direttore Finanziario/CFO presso FEMASYS INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Dov Elefant
Società | Posizione | Inizio | Fine |
---|---|---|---|
FEMASYS INC. | Direttore Finanziario/CFO | 28/02/2022 | - |
Storia della carriera di Dov Elefant
Precedenti posizioni note di Dov Elefant
Società | Posizione | Inizio | Fine |
---|---|---|---|
CELLECTAR BIOSCIENCES, INC. | Direttore Finanziario/CFO | 10/09/2019 | 23/02/2022 |
AKARI THERAPEUTICS, PLC | Direttore Finanziario/CFO | 11/01/2012 | 15/09/2019 |
Althera Medical Ltd.
![]() Althera Medical Ltd. Medical SpecialtiesHealth Technology Althera Medical Ltd. develops therapeutic devices for the treatment of various cancers. The private company is based in Bnei Braq, Israel. | Direttore Finanziario/CFO | 01/03/2011 | - |
Lev Pharmaceuticals, Inc.
![]() Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 16/03/2007 | 01/02/2009 |
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Direttore Amministrativo | 01/12/1999 | 01/03/2007 |
Comptroller/Controller/Auditor | 01/12/1999 | 01/03/2007 | |
Direttore Finanziario/CFO | 01/12/1999 | 01/03/2007 | |
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Comptroller/Controller/Auditor | 01/12/1999 | 01/03/2007 |
Direttore Finanziario/CFO | 01/12/1999 | 01/03/2007 | |
SYNVISTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/1998 | 01/12/1999 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Direttore operativo | 11/01/2012 | 31/03/2015 |
Direttore Finanziario/CFO | 11/01/2012 | - |
Formazione di Dov Elefant
Yeshiva University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Regno Unito | 2 |
Israele | 2 |
Posizioni
Director of Finance/CFO | 7 |
Comptroller/Controller/Auditor | 3 |
Chief Administrative Officer | 1 |
Settori
Health Technology | 9 |
Consumer Services | 2 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
SYNVISTA THERAPEUTICS, INC. | Health Technology |
AKARI THERAPEUTICS, PLC | Health Technology |
CELLECTAR BIOSCIENCES, INC. | Health Technology |
FEMASYS INC. | Electronic Technology |
Aziende private | 5 |
---|---|
EpiCept Corp.
![]() EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
Lev Pharmaceuticals, Inc.
![]() Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Health Technology |
Tetragenex Pharmaceuticals, Inc.
![]() Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Althera Medical Ltd.
![]() Althera Medical Ltd. Medical SpecialtiesHealth Technology Althera Medical Ltd. develops therapeutic devices for the treatment of various cancers. The private company is based in Bnei Braq, Israel. | Health Technology |
- Borsa valori
- Insiders
- Dov Elefant
- Esperienza